AI Verdict
VRTX has stronger fundamentals based on our AI analysis.
MRK vs VRTX Fundamental Comparison
| Metric | MRK | VRTX |
|---|---|---|
| Revenue | $16.3B | $3.0B |
| Net Income | $-4.2B | $1.0B |
| Net Margin | -26.0% | 34.5% |
| ROE | -9.2% | 5.3% |
| ROA | -3.3% | 3.9% |
| Current Ratio | 1.30x | 3.02x |
| Debt/Equity | 1.02x | 0.01x |
| EPS | $-1.72 | $4.02 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MRK vs VRTX: Frequently Asked Questions
Is MRK or VRTX the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), VRTX has stronger fundamentals. MRK is graded B (78% confidence) while VRTX is graded A (81% confidence). This is not investment advice.
How does MRK compare to VRTX fundamentally?
Merck & Co., Inc. has ROE of -9.2% vs VERTEX PHARMACEUTICALS INC / MA's 5.3%. Net margins are -26.0% vs 34.5% respectively.
Which stock pays higher dividends, MRK or VRTX?
MRK has a dividend yield of N/A or no dividend while VRTX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MRK or VRTX for long term?
For long-term investing, consider that MRK has a B grade with 78% confidence, while VRTX has a A grade with 81% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MRK vs VRTX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MRK vs VRTX, the AI consensus favors VRTX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.